Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.190
-0.030 (-2.46%)
At close: Nov 20, 2024, 4:00 PM
1.170
-0.020 (-1.68%)
After-hours: Nov 20, 2024, 5:20 PM EST
Plus Therapeutics Employees
Plus Therapeutics had 20 employees as of December 31, 2023. The number of employees increased by 3 or 17.65% compared to the previous year.
Employees
20
Change (1Y)
3
Growth (1Y)
17.65%
Revenue / Employee
$286,250
Profits / Employee
-$644,250
Market Cap
7.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Ontrak | 104 |
Syros Pharmaceuticals | 68 |
BioCardia | 20 |
Moleculin Biotech | 18 |
Edesa Biotech | 16 |
Galecto | 13 |
Cardio Diagnostics Holdings | 9 |
PSTV News
- 1 hour ago - Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases - GlobeNewsWire
- 4 days ago - Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 15 days ago - Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership - GlobeNewsWire
- 16 days ago - Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024 - GlobeNewsWire
- 23 days ago - Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas - GlobeNewsWire
- 7 weeks ago - Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting - GlobeNewsWire
- 2 months ago - Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting - GlobeNewsWire